Stay updated on LN-145 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the LN-145 in Solid Tumors Clinical Trial page.

Latest updates to the LN-145 in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedUpdate timestamps were added for 2026-05-22, 2026-05-19, and 2026-05, and older 2025-11 entries (2025-11-21, 2025-11-20, 2025-11) were removed from the update history.SummaryDifference0.2%

- Check12 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4. This indicates a new version of the study page (metadata change) with no changes to the study content.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page’s footer revision/version identifier was updated to a newer technical build (v3.5.3 instead of v3.5.2), with no visible changes to the study details.SummaryDifference0.0%

- Check41 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded Thyroid gland undifferentiated (anaplastic) carcinoma to the Conditions list. This expands the potential tumor types eligible for enrollment across the study.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision tag updated to v3.5.0. No trial details, eligibility criteria, or outcomes were changed.SummaryDifference0.0%

Stay in the know with updates to LN-145 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-145 in Solid Tumors Clinical Trial page.